National Health Investors (NHI) Stock Forecast, Price Target & Predictions
NHI Stock Forecast
National Health Investors stock forecast is as follows: an average price target of $72.20 (represents a -6.40% downside from NHI’s last price of $77.14) and a rating consensus of 'Hold', based on 6 wall street analysts offering a 1-year stock forecast.
NHI Price Target
The average price target for National Health Investors (NHI) is $72.20 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $92.00 to $61.00. This represents a potential -6.40% downside from NHI's last price of $77.14.
NHI Analyst Ratings
According to 6 Wall Street analysts, National Health Investors's rating consensus is 'Hold'. The analyst rating breakdown for NHI stock is 0 'Strong Buy' (0.00%), 2 'Buy' (33.33%), 4 'Hold' (66.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
National Health Investors Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 24, 2024 | Joshua Dennerlein | Bank of America Securities | $92.00 | $84.71 | 8.61% | 19.26% |
| Aug 30, 2024 | Michael Lewis | Truist Financial | $78.00 | $80.74 | -3.39% | 1.11% |
| Apr 03, 2024 | Michael Lewis | Truist Financial | $58.00 | $59.89 | -3.16% | -24.81% |
| Mar 12, 2024 | John Kim | National Bank | $67.00 | $59.56 | 12.49% | -13.14% |
| Feb 26, 2024 | Connor Siversky | Wells Fargo | $63.00 | $57.76 | 9.07% | -18.33% |
| Dec 09, 2022 | Tayo Okusanya | National Bank | $58.00 | $56.54 | 2.58% | -24.81% |
| Sep 26, 2022 | - | Truist Financial | $61.00 | $55.44 | 10.03% | -20.92% |
| Apr 18, 2022 | John Kim | BMO Capital | $61.00 | $54.59 | 11.74% | -20.92% |
The latest National Health Investors stock forecast, released on Sep 24, 2024 by Joshua Dennerlein from Bank of America Securities, set a price target of $92.00, which represents a 8.61% increase from the stock price at the time of the forecast ($84.71), and a 19.26% increase from NHI last price ($77.14).
National Health Investors Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 5 |
| Avg Price Target | - | $85.00 | $71.60 |
| Last Closing Price | $77.14 | $77.14 | $77.14 |
| Upside/Downside | -100.00% | 10.19% | -7.18% |
In the current month, the average price target of National Health Investors stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to National Health Investors's last price of $77.14. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 01, 2024 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| Sep 24, 2024 | Bank of America Securities | - | Buy | Initialise |
| Aug 23, 2024 | Wells Fargo | Overweight | Overweight | Hold |
| Apr 19, 2024 | BMO Capital | Outperform | Outperform | Hold |
| Mar 19, 2024 | Wedbush | Outperform | Neutral | Downgrade |
| Mar 12, 2024 | BMO Capital | Market Perform | Outperform | Upgrade |
| Feb 26, 2024 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| Feb 26, 2024 | Wedbush | - | Outperform | Upgrade |
| Dec 01, 2023 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
| Dec 09, 2022 | Credit Suisse | - | Neutral | Upgrade |
National Health Investors's last stock rating was published by Wells Fargo on Oct 01, 2024. The company Downgrade its NHI rating from "Overweight" to "Equal-Weight".
National Health Investors Financial Forecast
National Health Investors Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $67.74M | - | $82.39M | $70.67M | $76.30M | $59.90M | $71.33M | $69.67M | $73.83M | $74.33M | $80.89M | $81.24M | $84.30M | $84.17M | $83.08M | $82.19M | $81.68M |
| Avg Forecast | $90.43M | $89.63M | $88.85M | $87.85M | $69.93M | $72.28M | $71.24M | $70.89M | $69.62M | $67.93M | $64.95M | $64.93M | $64.21M | $62.58M | $58.86M | $61.86M | $61.04M | $62.49M | $65.74M | $70.78M | $65.60M | $68.95M | $71.59M | $78.01M | $77.60M | $75.04M | $76.96M | $75.84M | $75.37M | $73.22M |
| High Forecast | $99.56M | $98.69M | $97.82M | $96.72M | $76.99M | $79.58M | $78.44M | $78.01M | $77.52M | $69.00M | $64.95M | $64.93M | $64.34M | $64.12M | $64.80M | $68.11M | $67.20M | $62.49M | $65.74M | $70.78M | $65.60M | $68.95M | $71.59M | $78.01M | $77.60M | $75.04M | $76.96M | $75.84M | $75.37M | $73.22M |
| Low Forecast | $84.62M | $83.88M | $83.14M | $82.21M | $65.44M | $67.64M | $66.67M | $63.77M | $66.06M | $66.85M | $64.95M | $64.93M | $63.95M | $59.24M | $55.08M | $57.89M | $57.12M | $62.49M | $65.74M | $70.78M | $65.60M | $68.95M | $71.59M | $78.01M | $77.60M | $75.04M | $76.96M | $75.84M | $75.37M | $73.22M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 4 | 4 | 5 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 5 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | - | 1.33% | 1.16% | 1.22% | 0.91% | 1.01% | 1.06% | 1.07% | 1.04% | 1.04% | 1.05% | 1.12% | 1.09% | 1.10% | 1.09% | 1.12% |
National Health Investors's average Quarter revenue forecast for Dec 23 based on 5 analysts is $64.21M, with a low forecast of $63.95M, and a high forecast of $64.34M. NHI's average Quarter revenue forecast represents a -5.22% decrease compared to the company's last Quarter revenue of $67.74M (Sep 23).
National Health Investors EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 4 | 4 | 5 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 5 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $202.00K | - | $64.43M | $31.31M | $47.73M | $37.86M | $33.24M | $37.42M | $62.93M | $72.01M | $68.35M | $69.63M | $75.33M | $78.03M | $94.86M | $75.15M | $76.21M |
| Avg Forecast | $70.25M | $69.63M | $69.02M | $68.25M | $54.33M | $56.15M | $55.35M | $55.07M | $54.09M | $52.77M | $50.46M | $57.49M | $49.88M | $48.62M | $45.73M | $52.26M | $47.42M | $48.46M | $50.99M | $55.89M | $50.88M | $53.47M | $55.52M | $76.80M | $60.18M | $58.20M | $59.69M | $58.22M | $58.46M | $56.78M |
| High Forecast | $77.35M | $76.67M | $76.00M | $75.14M | $59.82M | $61.83M | $60.94M | $60.61M | $60.23M | $53.61M | $50.46M | $68.98M | $49.99M | $49.81M | $50.34M | $62.71M | $52.21M | $48.46M | $50.99M | $67.07M | $50.88M | $53.47M | $55.52M | $92.16M | $60.18M | $58.20M | $59.69M | $69.86M | $58.46M | $56.78M |
| Low Forecast | $65.74M | $65.16M | $64.59M | $63.86M | $50.84M | $52.55M | $51.79M | $49.54M | $51.32M | $51.94M | $50.46M | $45.99M | $49.68M | $46.02M | $42.79M | $41.81M | $44.37M | $48.46M | $50.99M | $44.71M | $50.88M | $53.47M | $55.52M | $61.44M | $60.18M | $58.20M | $59.69M | $46.57M | $58.46M | $56.78M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | - | 1.23% | 0.66% | 0.98% | 0.74% | 0.59% | 0.74% | 1.18% | 1.30% | 0.89% | 1.16% | 1.29% | 1.31% | 1.63% | 1.29% | 1.34% |
5 analysts predict NHI's average Quarter EBITDA for Dec 23 to be $49.88M, with a high of $49.99M and a low of $49.68M. This is 24593.18% upper than National Health Investors's previous annual EBITDA (Sep 23) of $202.00K.
National Health Investors Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 4 | 4 | 5 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 5 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $29.33M | - | $7.78M | $-10.27M | $23.43M | $11.21M | $-1.31M | $-5.14M | $30.81M | $39.18M | $35.33M | $37.14M | $42.59M | $44.37M | $61.02M | $42.04M | $42.76M |
| Avg Forecast | $36.67M | $36.24M | $36.03M | $35.46M | $35.46M | $35.39M | $34.78M | $32.89M | $33.20M | $32.15M | $31.82M | $13.33M | $29.94M | $31.67M | $30.35M | $12.12M | $11.86M | $33.54M | $31.80M | $12.96M | $40.30M | $37.68M | $38.77M | $39.70M | $44.14M | $38.99M | $43.78M | $37.45M | $41.17M | $41.39M |
| High Forecast | $41.49M | $41.00M | $40.76M | $40.12M | $40.12M | $40.04M | $39.35M | $33.46M | $34.09M | $32.29M | $31.82M | $15.99M | $30.50M | $33.87M | $34.34M | $14.54M | $14.23M | $33.54M | $31.80M | $15.55M | $40.30M | $37.68M | $38.77M | $47.64M | $44.14M | $38.99M | $43.78M | $44.94M | $41.17M | $41.39M |
| Low Forecast | $33.61M | $33.22M | $33.02M | $32.50M | $32.50M | $32.44M | $31.88M | $31.75M | $32.61M | $32.02M | $31.81M | $10.66M | $29.11M | $29.47M | $27.82M | $9.69M | $9.49M | $33.54M | $31.80M | $10.37M | $40.30M | $37.68M | $38.77M | $31.76M | $44.14M | $38.99M | $43.78M | $29.96M | $41.17M | $41.39M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.93% | - | 0.64% | -0.87% | 0.70% | 0.35% | -0.10% | -0.13% | 0.82% | 1.01% | 0.89% | 0.84% | 1.09% | 1.01% | 1.63% | 1.02% | 1.03% |
National Health Investors's average Quarter net income forecast for Dec 23 is $29.94M, with a range of $29.11M to $30.50M. NHI's average Quarter net income forecast represents a 2.10% increase compared to the company's last Quarter net income of $29.33M (Sep 23).
National Health Investors SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 4 | 4 | 5 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 5 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $4.43M | - | $5.78M | $5.17M | $4.83M | $5.39M | $9.93M | $3.90M | $3.77M | $3.55M | $8.12M | $3.60M | $3.03M | $3.28M | $4.64M | $3.71M | $2.84M |
| Avg Forecast | $5.52M | $5.47M | $5.42M | $5.36M | $4.27M | $4.41M | $4.35M | $4.33M | $4.25M | $4.15M | $3.96M | $15.75M | $3.92M | $3.82M | $3.59M | $14.32M | $7.15M | $3.81M | $4.01M | $15.32M | $4.00M | $4.21M | $4.37M | $9.12M | $4.74M | $4.58M | $4.70M | $2.85M | $4.60M | $4.47M |
| High Forecast | $6.08M | $6.02M | $5.97M | $5.90M | $4.70M | $4.86M | $4.79M | $4.76M | $4.73M | $4.21M | $3.96M | $18.90M | $3.93M | $3.91M | $3.96M | $17.19M | $8.58M | $3.81M | $4.01M | $18.38M | $4.00M | $4.21M | $4.37M | $10.95M | $4.74M | $4.58M | $4.70M | $3.42M | $4.60M | $4.47M |
| Low Forecast | $5.17M | $5.12M | $5.07M | $5.02M | $3.99M | $4.13M | $4.07M | $3.89M | $4.03M | $4.08M | $3.96M | $12.60M | $3.90M | $3.62M | $3.36M | $11.46M | $5.72M | $3.81M | $4.01M | $12.25M | $4.00M | $4.21M | $4.37M | $7.30M | $4.74M | $4.58M | $4.70M | $2.28M | $4.60M | $4.47M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.16% | - | 0.40% | 0.72% | 1.27% | 1.34% | 0.65% | 0.97% | 0.90% | 0.81% | 0.89% | 0.76% | 0.66% | 0.70% | 1.63% | 0.81% | 0.64% |
National Health Investors's average Quarter SG&A projection for Dec 23 is $3.92M, based on 5 Wall Street analysts, with a range of $3.90M to $3.93M. The forecast indicates a -11.53% fall compared to NHI last annual SG&A of $4.43M (Sep 23).
National Health Investors EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 4 | 4 | 5 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 5 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.68 | - | $0.18 | $-0.24 | $0.53 | $0.25 | $-0.03 | $-0.11 | $0.67 | $0.85 | $0.78 | $0.83 | $0.95 | $0.99 | $1.37 | $0.95 | $0.98 |
| Avg Forecast | $0.83 | $0.82 | $0.82 | $0.81 | $0.81 | $0.80 | $0.79 | $0.75 | $0.75 | $0.73 | $0.72 | $0.68 | $0.68 | $0.72 | $0.69 | $0.66 | $0.83 | $0.77 | $0.73 | $0.63 | $0.93 | $0.86 | $0.89 | $0.89 | $1.01 | $0.90 | $1.00 | $0.95 | $0.94 | $0.95 |
| High Forecast | $0.94 | $0.93 | $0.93 | $0.91 | $0.91 | $0.91 | $0.89 | $0.76 | $0.78 | $0.73 | $0.72 | $0.68 | $0.69 | $0.77 | $0.78 | $0.75 | $0.94 | $0.77 | $0.73 | $0.63 | $0.93 | $0.86 | $0.89 | $0.89 | $1.01 | $0.90 | $1.00 | $0.95 | $0.94 | $0.95 |
| Low Forecast | $0.76 | $0.76 | $0.75 | $0.74 | $0.74 | $0.74 | $0.72 | $0.72 | $0.74 | $0.73 | $0.72 | $0.68 | $0.66 | $0.67 | $0.63 | $0.60 | $0.76 | $0.77 | $0.73 | $0.63 | $0.93 | $0.86 | $0.89 | $0.89 | $1.01 | $0.90 | $1.00 | $0.95 | $0.94 | $0.95 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.94% | - | 0.27% | -0.29% | 0.69% | 0.34% | -0.05% | -0.12% | 0.77% | 0.96% | 0.88% | 0.82% | 1.06% | 0.99% | 1.43% | 1.01% | 1.03% |
According to 5 Wall Street analysts, National Health Investors's projected average Quarter EPS for Dec 23 is $0.68, with a low estimate of $0.66 and a high estimate of $0.69. This represents a 0.11% increase compared to NHI previous annual EPS of $0.68 (Sep 23).
National Health Investors Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| GMRE | Global Medical REIT | $8.64 | $11.75 | 36.00% | Buy |
| CHCT | Community Healthcare Trust | $18.39 | $22.33 | 21.42% | Buy |
| HR | Healthcare Realty Trust | $17.56 | $19.00 | 8.20% | Buy |
| OHI | Omega Healthcare Investors | $39.88 | $38.62 | -3.16% | Buy |
| VTR | Ventas | $64.11 | $61.34 | -4.32% | Buy |
| SBRA | Sabra Health Care REIT | $18.39 | $17.29 | -5.98% | Hold |
| NHI | National Health Investors | $77.14 | $72.20 | -6.40% | Hold |